Tempus AI: Taking Advantage Of Investor Myopia
Tempus AI Inc TEM
$46.26
▼ -0.49%
($-0.23)
Open
$46.81
Prev Close
$46.49
Day Range
$45.84 – $47.77
52W Range
$41.73 – $104.32
Market Cap
$8.53B
Beta
2.47
EPS (TTM)
$-1.71
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-05-30 |
| Shares Out. | 179,560,000 |
| Website | investors.tempus.com/ ↗ |
| Phone | 18335144187 |
Tempus AI Inc is a publicly traded company under the ticker symbol TEM on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for TEM
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
Undercovered Dozen: Sivers Semiconductors, LandBridge, Hercules Capital, And More
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts
Tempus AI Partners With Bristol Myers Squibb Over Leveraging AI, Multimodal Real-World Data, Data Science Techniques For Clinical Trial Designs
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Ark Invest Again Sells AMD, This Time As Stock Hits 52-Week High While Snapping Up Tempus AI And Circle